Women on weight-loss medication may have a lower risk of developing breast cancer, according to a new study. View on euronews ...

The story of GLP-1 drugs keeps getting bigger. First they transformed the treatment of diabetes. Then they upended the ...

A retrospective analysis of more than 110,000 women between the ages of 45 and 80 found that those who took GLP-1 medications ...

GLP-1 drugs aren’t just reducing weight — they may also be reducing the chances of developing one of the most common and ...

A surprising new study suggests that when it comes to pancreatic cancer, the kind of fat you eat may matter more than how ...

Women taking popular GLP-1 weight loss drugs like Ozempic and Wegovy had a 30 percent reduced risk of developing breast ...

A distinct signaling pathway called TNF- drives the transformation of epithelial cells into aggressive tumor cells. During cancer progression, cells activate their own TNF- program and become invasive ...

AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced a significant milestone in its pancreatic cancer development program, with enrollment of the final subject, barring ...

An artificial intelligence model from the Mayo Clinic detected early signs of possible pancreatic cancer on scans up to two years before patients were diagnosed.

Cancer has been one of the hardest health conditions to find a solution to in the world and Pancreatic Cancer being one among ...